#BrainEver
LightNews LightNews
on-health.bsky.social
🧠 La #biotech française #BrainEver vient de lever 33 millions d’euros pour lancer un essai clinique en Europe contre la #MaladiedeCharcot.

🔬 Sa technologie de reprogrammation neuronale ouvre une nouvelle voie thérapeutique face à la #SLA.

📲 on-health.tv/brainever-in...
BrainEver innove pour stopper l'évolution de la maladie de Charcot - ON HEALTH
BrainEver a développé une plateforme de reprogrammation neuronale pour stopper l'évolution de la maladie de Charcot.
on-health.tv
July 18, 2025 at 7:17 AM
longtail-news.bsky.social
Feed: "Endpoints News"
By: ENDPOINTS on Thursday, July 3, 2025
Cloudbreak’s shares stumble in Hong Kong debut; Sinovac squares off against activist
Plus, news about BrainEver, Clinigen, MaaT Pharma, Dyadic and Nektar Therapeutics.
endpoints.news
July 4, 2025 at 7:11 PM
drtimos.bsky.social
Thoughts on this? >> Cloudbreak’s shares stumble in Hong Kong debut; Sinovac
squares off against activist >> Comment below! #strategy #competitiveintelligence #marketing #biotech #productmarketing #pharmaceutical #pharma #healthcare
Cloudbreak’s shares stumble in Hong Kong debut; Sinovac squares off against activist
Plus, news about BrainEver, Clinigen, MaaT Pharma, Dyadic and Nektar Therapeutics: Cloudbreak Pharma shares fall in Hong Kong debut: The ophthalmology biotech, which has offices in California and China, went public on the Hong Kong ...
dlvr.it
July 3, 2025 at 3:37 PM